13F-HR filed by Carlyle Group Inc.
Carlyle Group Inc. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-07, with 19 holding rows worth $10,000,861,951.
- Accession
- 0000898432-26-000602
- Filer
- CIK 1527166
- Filed
- 2026-08-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A combination report, 19 entries on the cover page, a total value of $10,000,861,951 stated on the cover page (in dollars after the unit check, H1), rows summing to $10,000,861,951 with VALUE read as dollars as filed, 13F file number 028-15025. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerAlpInvest Partners B.V.028-15646
- included managerAbingworth LLP028-14285
- included managerCarlyle Investment Management LLC028-12429
- included managerCIM Global, L.L.C.028-15024
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MEDLINE INC COM CL A | 58507V107 | Stock | 187,083,713 | $7,378,581,641 | dollars as filed | |
| STANDARDAERO INC COM | 85423L103 | Stock | 84,587,035 | $2,529,998,217 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 3,496,808 | $37,940,367 | dollars as filed | |
| INVITATION HOMES INC COM | 46187W107 | REIT | 662,900 | $20,026,209 | dollars as filed | |
| PONY AI INC | 732908108 | SPONSORED ADS | 2,362,447 | $16,419,007 | dollars as filed | |
| GETTY IMAGES HOLDINGS INC | 374275105 | CL A COM | 6,234,252 | $5,361,457 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 38,620 | $2,085,493 | dollars as filed | |
| SUNPOWER INC | 20460L104 | COM | 2,343,750 | $1,610,859 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 184,295 | $1,592,308 | dollars as filed | |
| FORWARD AIR CORP COM | 34986A104 | Stock | 107,214 | $1,448,461 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 269,895 | $1,230,721 | dollars as filed | |
| KRISPY KREME INC | 50101L106 | COMMON STOCK | 340,748 | $1,202,840 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 60,363 | $769,020 | dollars as filed | |
| RILEY EXPLORATION PERMIAN IN | 76665T102 | COM | 16,092 | $530,387 | dollars as filed | |
| NEBIUS GROUP N.V. | N97284108 | SHS CLASS A | 1,846 | $509,810 | dollars as filed | |
| ROBINHOOD MKTS INC | 770700102 | COM | 4,733 | $474,625 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,066,189 | $448,866 | dollars as filed | |
| N-ABLE INC COMMON STOCK | 62878D100 | Stock | 93,732 | $343,996 | dollars as filed | |
| RAMACO RES INC | 75134P600 | COM CL A | 21,743 | $287,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000898432-26-000602 | this filing | 2026-08-07 | acceptance time not in the bulk data set |